Effectiveness of oral tramadol hydrochloride for chronic non-malignant pain

Japanese Journal of Anesthesiology

Volumn 58, Issue 8, 2009, Pages 971-975

  Kttahara, Masaki ^a   Kojima, Keiko ^a   Hanada, Maki ^b   Kuriyama, Youko ^b   Ohmura, Akito ^b  

^a JIKEI UNIVERSITY HOSPITAL   (Japan)

^b TEIKYO UNIVERSITY MIZONOKUCHI HOSPITAL   (Japan)

Author keywords

Addiction; Chronic non malignant pain; Oral administration; Tramadol

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; TRAMADOL;

ANALGESIA; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; HUMAN; JAPAN; MYOFASCIAL PAIN; NAUSEA; NEUROPATHIC PAIN; RATING SCALE; WORLD HEALTH ORGANIZATION;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; SUBSTANCE-RELATED DISORDERS; TRAMADOL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 69549084819     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Scott LJ, Perry CM. Tramadol : a review of its use in perioperative pain. Drugs 2000 ; 60 : 139-176 (Pubitemid 30598822)
2. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet 2004 ; 43 : 879-923.
3. Shipton EA. Tramadol-present and future. Anaesth Intensive Care 2000 ; 28 : 363-374
4. Cicero TJ, Adams EH, Geller A, Inciardi JA, Munoz A, Schnoll SH, et al. A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States. Drug Alcohol Depend 1999 ; 57 : 7-22. (Pubitemid 29452951)
5. Knisely JS, Campbell ED, Dawson KS, Schnoll SH. Tramadol post-marketing surveillance in health care professionals. Drug Alcohol Depend 2002 ; 68 : 15-22. (Pubitemid 34880038)
6. Loeser JD, Turk DC. Multidisciplinary pain management. In : Loeser JD, Butler SH, Chapman CR, et al, editors. Bonica's Management of Pain. 3rd ed. Philadelphia : Lippincott Williams & Wilkins ; 2001. p.2069-2079
7. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther 1992 ; 260 : 275-285
8. Gillen C, Haurand M, Kobelt DJ, Wnendt S. Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor. Naunyn Schmiedebergs Arch Pharmacol 2000 ; 362 : 116-121 (Pubitemid 30640039)
9. Basbaum AI, Fields HL. Endogenous pain control mechanisms : review and hypothesis. Ann Neurol 1978 ; 4 : 451-462 (Pubitemid 9030389)
10. Hollingshead J, Duhmke RM, Cornblath DR. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2006 ; 3 : CD003726.
11. Harati Y, Gooch C, Swenson M, Edelman SV, Greene D, Raskin P, et al. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complications 2000 ; 14 : 65-70. (Pubitemid 30665755)
12. WHO Expert Committee on Drug Dependence. Thirty-fourth report. http://whqlibdoc.who.int/trs/WHO-TRS-942-eng.pdf. (2007)
13. Eriksen J, Jensen MK, Sjogren P, Ekholm O, Rasmussen NK. Epidemiology of chronic non-malignant pain in Denmark. Pain 2003 ; 106 : 221-228
14. Thomas E, Peat G, Harris L, Wilkie R, Croft PR. The prevalence of pain and pain interference in a general population of older adults : cross-sectional findings from the North Staffordshire Osteoarthritis Project (NorStOP). Pain 2004 ; 110 : 361-368 (Pubitemid 38953301)